Implantable cardioverter defibrillator therapy in athletes

被引：21
|
作者：
Heidbuechel, Hein [1 ]
机构：
[1] Univ Leuven, Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium
来源：
CARDIOLOGY CLINICS | 2007年 / 25卷 / 03期
关键词：
D O I：
10.1016/j.ccl.2007.07.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Implantable cardioverter defibrillators (ICD) prevent recurrent arrhythmic death in sudden death survivors or may prevent its development in physically active patients with an underlying risk for malignant ventricular arrhythmias. Although ICD do not substitute for the usual recommendations to refrain from intensive or competitive exercise because of an underlying arrhythmic disorder, they often provide a means for safe continuation of mild to moderate recreational sports activity. Long-term quality of life will be highly dependent on the prevention of inappropriate ICD shocks. This requires the choice of a durable lead and device system, careful programming tailored to the characteristics of the patient's physiologic and pathologic heart rhythms, preventive bradycardic medication, and guided rehabilitation with psychologic counseling.
引用
收藏
页码：467 / +
页数：17
相关论文
共 50 条
  • [31] Improvements in 25 Years of Implantable Cardioverter Defibrillator Therapy
    van Welsenes, G. H.
    Borleffs, C. J. W.
    van Rees, J. B.
    Atary, J. Z.
    Thijssen, J.
    van der Wall, E. E.
    Schalij, M. J.
    NETHERLANDS HEART JOURNAL, 2011, 19 (01) : 24 - 30
  • [32] Deficiencies in Patients' Comprehension of Implantable Cardioverter Defibrillator Therapy
    Groarke, John
    Beirne, Avril
    Buckley, Una
    O'Dwyer, Elisabeth
    Sugrue, Declan
    Keelan, Ted
    O'Neill, James
    Galvin, Joe
    Mahon, Niall
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2012, 35 (09): : 1097 - 1102
  • [33] Experience with implantable cardioverter defibrillator therapy in elderly patients
    Geelen, P
    Lorga, A
    Primo, J
    Wellens, F
    Brugada, P
    EUROPEAN HEART JOURNAL, 1997, 18 (08) : 1339 - 1342
  • [34] Implantable Cardioverter Defibrillator Therapy in Patients with Cardiac Sarcoidosis
    Schuller, Joseph L.
    Zipse, Matthew
    Crawford, Thomas
    Bogun, Frank
    Beshai, John
    Patel, Amit R.
    Sweiss, Nadera J.
    Nguyen, Duy T.
    Aleong, Ryan G.
    Varosy, Paul D.
    Weinberger, Howard D.
    Sauer, William H.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2012, 23 (09) : 925 - 929
  • [35] Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication
    Schaer, Beat
    Kuehne, Michael
    Reichlin, Tobias
    Osswald, Stefan
    Sticherling, Christian
    EUROPACE, 2016, 18 (02): : 227 - 231
  • [36] Growth and the implantable cardioverter defibrillator
    McLeod, KA
    Rankin, A
    Pollock, J
    HEART, 2000, 83 (03) : 277 - 277
  • [37] ECT with implantable cardioverter defibrillator
    Pornnoppadol, C
    Isenberg, K
    JOURNAL OF ECT, 1998, 14 (02) : 124 - 126
  • [38] Preventing premature implantable cardioverter defibrillator therapy (ICD) by using the wearable cardioverter-defibrillator (WCD)
    Waessnig, N.
    Guenther, M.
    Quick, S.
    Wiedemann, S.
    Heidrich, F.
    Sveric, K.
    Strasser, R.
    Ibrahim, K.
    Speiser, U.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1378 - 1378
  • [39] Subcutaneous Implantable Cardioverter Defibrillator
    Rowley, Christopher P.
    Gold, Michael R.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2012, 5 (03): : 587 - 593
  • [40] IMPLANTABLE CARDIOVERTER DEFIBRILLATOR - A REVIEW
    MASON, P
    MCPHERSON, C
    HEART & LUNG, 1992, 21 (02): : 141 - 147
12345